Vasella: No Rush To Make A Deal

Make a comment

vasella.jpg

For now, on talks are under way to snap up a rival with the $5.5 billion from the sale of Gerber baby food to Nestle, says the Novartis ceo.

“No, in that sense there is no concrete project at this time … patience pays off, because an acquiring company runs the risk of paying too much if it acts too agitated,” Dan tells Swiss newspaper Le Temps. “But obviously we’re always trying to find interesting acquisitions.”

.
Source: Reuters[tags]Dan Vasella, Novartis[/tags]

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/